Quantifies volumetric asymmetries in patients with drug-resistant epilepsy, indicating critical structural differences.
To quantify amygdala and hippocampal volumetric asymmetries in patients with drug-resistant epilepsy (DRE) and extra-medial temporal lesions (EMTLs), and to assess the prevalence of structural alterations relative to drug resistant temporal lobe epilepsy (TLE), extratemporal lobe epilepsy (ETLE), and healthy individuals.
No takes yet. Share an insight, caveat, or question.
Serlin et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: